Health News

AtheroMed Announces Completion of Patient Enrollment in the EASE Study Evaluating the Phoenix Atherectomy System in Treating PAD

Author: Australian Business

MENLO PARK, Calif., Oct. 2, 2013 /PRNewswire/ -- AtheroMed, a developer of innovative technologies for treating peripheral artery disease (PAD), announced that it has completed patient enrollment in the EASE clinical study. The EASE study results will be presented by Dr. Stephen Williams,......

More...

More Articles...

LCA-Vision Reports 4% Increase in Third Quarter 2013 Procedures
Ambit Announces Participation At 12th Annual BIO Investor Forum
PDL BioPharma Provides $60 Million in Financing to LENSAR
US and European Regulators Accept for Review OMS302 Marketing Applications
El NHS de Inglaterra designa a SIRT (radioterapia interna selectiva) como el primer tratamiento disponible a través de la nueva iniciativa "Commissioning through Evaluation"
Expatriates Could be Paying Too Much For International Private Medical Insurance
NHS England torna a SIRT (Radioterapia Seletiva Interna) o primeiro tratamento disponível através da nova iniciativa de comissionamento por avaliação
KLOX Technologies annonce l'approbation au Canada de son traitement novateur contre l'acné simple
Nutranomics Receives Purchase Order from GNC Franchise Owners in the Philippines
VG Life Sciences, Inc. Closes on $2,235,000 from Private Fund

Page 1261 of 1908